CFDE Data Portal | Search SMG1P5

	Label	Description
	SMG1P5 associations Collection (Entity type)	Associations for SMG1P5_associations
	SMG1P5 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SMG1P5 Gene (Entity type)	ENSG00000291266 - SMG1 pseudogene 5
	GSE239844 crizotinib 8 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE157109 TRIM8 knockdown MCF-7 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE190076 H-7 Huh-7 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 5 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 trametinib NF1 10 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE153354 TCF19 knockout CAL-27 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

SMG1P5 associations

Associations for SMG1P5_associations

SMG1P5 associations.tsv

A file from IDG as part of the Harmonizome project

SMG1P5

ENSG00000291266 - SMG1 pseudogene 5

GSE239844 crizotinib 8 v 10 human dn

A Gene Set from LINCS

GSE157109 TRIM8 knockdown MCF-7 0 v 1 human up

A Gene Set from LINCS

GSE190076 H-7 Huh-7 0 v 1 human up

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 5 v 0 human dn

A Gene Set from LINCS

GSE213588 trametinib NF1 10 v 12 human up

A Gene Set from LINCS

GSE153354 TCF19 knockout CAL-27 0 v 1 human dn

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 7 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.